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Abstract
Background: This study aimed to evaluate the pterygium recurrence rate and corneal stabilization point after pterygium
excision via the controlled partial avulsion fibrin glue technique using multiple corneal parameters. Methods: One
hundred eyes of 100 patients who had undergone primary pterygium excision surgery via the controlled partial avulsion
fibrin glue technique were retrospectively reviewed. Corneal stabilization points were determined over four follow-up
sessions (i.e., the 1st, 3rd, 6th, and 12th months after surgery) based on changes in Simulated-K, corneal irregularity
measurement, shape factor, and toric mean keratometry. Post-operative courses were followed for 12 months after
surgery. Recurrence was deﬁned as the regrowth of ﬁbrovascular tissue 1 mm past the corneoscleral limbus. Results:
No sign of pterygium recurrence and the corneal stabilization point were observed at the third month post-operation.
Significance improvements in all corneal parameters were noted between the 1st and 3rd months (both p < 0.001);
however, insignificant changes were noted at the following 6th- and 12th-month visits (both p > 0.05). Conclusion: The
controlled partial avulsion fibrin glue technique may improve surgical outcomes with long-term recurrence rates equal
to or lower than those previously reported. Corneal surface recovery is completed after the third month of the excision
procedure.
Keywords: cornea, fibrin tissue adhesive, pterygium, recurrence

therapy using antimetabolites and ß-irradiation,10–13
adjuvant surgery via conjunctival autograft,11,14,15
amniotic membrane transplantation,13,16 and the fibrin
glue adhesive method.17,18

Introduction
A common chronic non-communicable disease in tropical
countries is pterygium, which is due to prolonged
exposure to ultraviolet rays. Pterygium refers to a
corneo-limbal disorder characterized by the abnormal
growth of fibrovascular tissue originating from bulbar
conjunctiva into the cornea. In terms of histology,
pterygium is composed of the head of the conjunctival
epithelium and hyperproliferative vascularization along
the body of the degenerated connective tissue, which
signifies elastolic degeneration.1–3 Because of these
distinct characteristics, pterygium was previously
considered to be a degenerative disorder. However,
recent studies have proven that pterygium also has
proliferative histological characteristics, such as mild
dysplasia, local invasiveness, and abnormal p53 gene
expression, and clinical features, notably a high
recurrence rate following excision.4–9 The primary
treatment for pterygium is surgical excision. Indeed,
over the last two decades, several new approaches in
surgical techniques have been proposed and promising
success rates have been obtained. Some of these novel
treatment modalities include bare sclera,10 adjuvant

The exact mechanisms or causes of pterygium
proliferation remain unknown. However, the tendency
of a pterygium to proliferate is most prominent when it
recurs after excision. Aggressive fibrovascular proliferation
is more common in recurrent pterygium compared with
primary pterygium. Several studies have addressed
pterygium recurrence and its incidence after pterygial
tissue excision,18–20 and surgical results may vary
greatly according to the preoperative demographics,
surgical techniques,13,14–18 and adjunctive treatments10–15
applied. Although a number of treatment options to
manage pterygium are available, the primary outcome is
still the same which is to explore treatment approach
that provides minimum post-operative complications for
patients and shorter operating time for surgeons.
The present study aims to evaluate the pterygium
recurrence rate and corneal stabilization point
subsequent to pterygium excision using the controlled
140
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partial avulsion fibrin glue technique by evaluating
changes in four corneal indices, namely, simulated-K
(SimK), corneal irregularity measurement (CIM), shape
factor (SF), and mean toric keratometry (TKM). Bestcorrected visual acuity (BCVA) and contrast sensitivity
function (CSF) with emphasis on oculovisual function
were also evaluated. These parameters comprehensively
represent changes in the anterior corneal surface and
visual performance.

Methods
Study design. One hundred primary pterygium eyes
from 100 patients who voluntarily participated in this
prospective cohort study and visited a university eye
specialist were recruited to this study to incorporate a
wide range of pterygium severities in the analysis. All
participants underwent full comprehensive optometric
examination by a certified optometrist (MRH) and a
consultant ophthalmologist (KMK). The number of
participants recruited for this study was calculated
according to the mean difference in corneal astigmatism
(SimK) between pre- and 3-month post-operative
patients reported in a previous study using Power and
Sample Size Calculation software (Version 3.1.2; PS
software, Nashville, TN, USA).8 The calculations
revealed that a minimum number of 60 participants are
required to achieve the desired level of significance
(power, 90%; p < 0.05).
Inclusion and exclusion criteria. All participants in
this study were selected based on specific criteria. The
inclusion criteria were an established diagnosis of
primary pterygium, patients of either gender with ages
between 20 and 70 years, and no history of ocular
trauma, ocular surgery, and contact lens wear.21–24
Patients with significant ocular surface diseases, such as
recurrent pterygium, corneal irregularity, and opacity
due to diseases other than pterygium, were excluded.
Patients for whom corneal topography could not provide
reproducible measurements due to obstruction of the
central cornea by pterygium were also excluded. This
study was conducted according to the principles of the
Declaration of Helsinki and approved by the ethical
research committee of International Islamic University
Malaysia (IIUM/310/G13/4/4-125). Written consent forms
were obtained from all participants after they were
explained the objectives and consequences of the study.
Pterygium Classification. Pterygium was classified
according to Tan’s classification, and clinical grading
was based on the translucence of the growth. Tan’s
classification of pterygium divides pterygium into types
of atrophy, intermediate, and fleshy. Grade I (atrophy)
pterygium is defined as growth in which the underlying
episcleral vessels are unobscured and clearly
distinguished. Grade II (intermediate) pterygium is
defined as a growth in which details of the episcleral
Makara J Health Res.
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vessel are indistinct or partially obscured. Finally,
Grade III pterygium (fleshy) is defined as growth in
which the underlying episcleral vessels are completely
obscured. In the present study, diagnosis and
classification of primary pterygium were conducted by a
single consultant ophthalmologist (KMK).
Study procedures. All participants underwent standard
optometric examination comprising dry refraction, slitlamp examination, and fundus examination. Then, each
participant’s average central corneal curvature (SimK
and CIM) and overall corneal curvature (SF and TKM)
indices were objectively measured using Zeiss
ATLAS™ 995 corneal topographers (Zeiss Meditec,
Inc., Dublin, USA). Visual performance parameters
(BCVA and CSF) were measured using an M&S
Technologies Smart System II instrument (SSII, Park
Ridge, IL, USA). The setting of this system is similar to
those described in previous studies.21 Three
measurements were taken, and the measurement with
the best image quality was taken as the final
measurement value. All measurements were carried out
by a single operator and performed on the same visit.
Then, all participants underwent pterygium excision as
described in detail below; all operations were performed
by a single surgeon (KMK). All participants were then
followed up for a 1-year period divided into four
sessions (i.e. the 1st, 3rd, 6th, and 12th months postoperation), and all corneal indices were measured
following procedures established during the pre-surgical
session.25–28 The same operator performed all
procedures for all sessions. Photographs were taken on
each data collection session to determine pterygium
recurrence, which was defined as any fibrovascular
growth 1 mm past the corneoscleral limbus and into the
clear cornea.29
Data analysis. Statistical analysis were performed using
IBM SPSS (Version 19, SPSS Inc., Chicago, IL, USA).
The normality of the data was evaluated using the ratio
of skewness to kurtosis; here, a ratio of ± 2.50 was
considered to indicate a normal distribution.30
Comparisons of the mean of each set of measurements
for all parameters were performed using one-way
analysis of variance (ANOVA). Repeated-measures
one-way ANOVA was then employed to determine
significant differences in all intended parameters
between all five sessions. Bonferroni post hoc analysis
was employed to determine the session with the most
significant changes, and statistical significance was
established at p < 0.05.
Surgical procedures. This study adopted a standardized
procedure for all 100 pterygium samples, and a single
surgeon (KMK) performed the operations via a
standardized surgical method. All of the surgical
procedures were performed as day-care operations under
topical and subconjunctival anesthesia. Specifically, the
August 2020 | Vol. 24 | No. 2
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body of the pterygium was dissected 4 mm from the
limbus and reflected over the cornea, a removal of the
pterygium head was continued using a Beaver No. 64
surgical blade (Becton Dickenson, Waltham, Mass) via
the blunt dissection technique. Excessive tenons were
cleared from the bare area, and limbus regions were
polished and smoothened using a 3.3 mm diamond burr
(Katena ophthalmic burr (No. K2-4920), Katena
diamond burr 3.3 mm diameter ball (No. K2-4923),
Katena Product Inc., NJ, USA).
All eyes received a conjunctival autograft. A superficial
thin free conjunctival graft was carefully dissected from
the superior bulbar conjunctiva to avoid taking the
underlying Tenon’s layer. Grafts were pre-measured to
be oversized by 1 mm horizontally and vertically
compared with the bare sclera defect. Graft margins
were glued using fibrin glue (Tisseel™, Baxter AG,
Vienna, Austria) at the scleral area. All patients received
gutt 5 ml of 0.5% moxifloxacin (Alcon Laboratories,
Fort Worth, TX, USA) qid, gutt 5 ml of 0.1%
dexamethasone (Alcon Laboratories) qid, and 0.3 ml
0.18% Vismed® preservative-free artificial tear drops

(TRB Chemedica International SA, Geneva, Switzerland)
qid on both eyes for 3 weeks post-operation.

Results
The present analysis included 100 participants, 55% (n
= 55) of whom were men. Normality testing showed that
all data (i.e., SimK, CIM, SF, TKM, BCVA, and CSF)
were normally distributed. Demographic data revealed
that the average means for all intended parameters were
within the normal range and had fairly large standard
deviations (SDs). This finding could be explained by the
inclusion of different grades of primary pterygium to
reflect the clinical epidemiological data of the population
comprehensively. ANOVA showed that the average
means for all data measurements were consistent at
baseline (p > 0.05). This finding confirms that all data
included in the analysis are reliable. Moreover, a
decreasing trend in all four corneal parameters (SimK,
CIM, SF and TKM) and both visual performance
(BCVA and CSF) measurements was observed from
baseline (pre-surgery) to the 12th-month follow-up.

Table 1. Comparative analysis of corneal topographic parameters between pre- and post-surgical excision patients over 1 year of
follow up (N = 100)
Follow up schedule (mean±SD)
Variables

p*
Baseline

SimK (D)

CIM

SF

TKM (D)

BCVA (LogMAR)

CSF (%)

4.64±4.18

4.31±5.30

0.55±0.20

46.95±4.47

0.44±0.30

24.28±17.66

1 montha

0.63±0.43

1.87±2.32

0.41±0.14

46.61±4.32

0.20±0.12

8.74±4.47

3 monthsb

0.57±0.45

0.53±0.30

0.33±0.08

46.51±4.27

0.12±0.04

6.32±0.89

6 monthsc

0.57±0.45

0.53±0.30

0.33±0.08

46.52±4.27

0.13±0.05

6.29±0.92

12 monthsd

0.57±0.44

< 0.001a
< 0.001b
= 0.165c
= 0.392d

0.53±0.30

< 0.001a
< 0.001b
= 0.399c
= 0.449d

0.33±0.08

< 0.001a
< 0.001b
= 0.892c
= 0.671d

46.49±4.28

< 0.001a
< 0.001b
= 0.158c
= 0.158d

0.12±0.05

< 0.001a
< 0.001b
= 0.208c
= 0.158d

6.27±0.93

< 0.001a
< 0.001b
= 0.083c
= 0.158d

* Repeated measure of analysis of variance (RM-ANOVA), significance level set at 0.05 (2-tailed)
a
c
between baseline and 1-month
between 3-month and 6-month
b
d
between 1-month and 3-month
between 6-month and 12-month
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Corneal parameters. RM-ANOVA indicated that all
corneal parameters measured showed a significant
change within the first 3 months of follow-up followed
by a plateau. The mean±SD of SimK, for example, was
highest at baseline (4.64±4.18 Diopters (D)) and
significantly decreased to 0.63±0.43 D within the first
month post-surgery (p < 0.001). SimK showed a similar
decreasing trend until the third month post-surgery
(0.57±0.45 D; p < 0.001). However, no significant
difference in SimK between the 6th month (0.57±0.45
D) and 12th month (0.57±0.44 D) post-surgery was
observed (both p > 0.05).
The other corneal indices, namely, CIM, SF, and TKM,
showed trends similar to that observed in SimK;
specifically, these indices significantly decreased from
baseline to the first month (p < 0.001) and from the first
month to the third month (p < 0.001) post-surgery.
Moreover, no significant difference between the fourth
(6 months) and fifth (12 months) follow-up sessions
were noted for CIM, SF, and TKM (all p > 0.05).
BCVA and CSF revealed prominent improvements
within the first 3 months after surgery and then tended
to plateau thereafter. The average BCVA decreased
from 0.44±0.30 LogMAR at baseline to 0.20±0.12
LogMAR at 1-month post-surgery and then to
0.12±0.04 at 3 months post-surgery (both p < 0.001).
CSF significantly decreased from 24.28%±17.66% at
baseline to 8.74%±4.47% at 1-month post-surgery and
then to 6.32%±0.89% at 3 months post-surgery (both p
< 0.001). Both parameters revealed no significant
changes from the third month onward. All pre-and postsurgical results are summarized in Table 1.
The results of the current study suggest that the corneal
stabilization point occurs at the third month postsurgery because all corneal indices returned to their
original values at this timepoint, which suggests that the
anterior corneal curvature had recovered. Moreover,
zero recurrences of pterygium were observed after 12
months of follow-up.

Discussion
This study evaluates the pterygium recurrence rate and
corneal stabilization point subsequent to pterygium
excision using the controlled partial avulsion fibrin
glue technique by evaluating magnitude changes in
four corneal indices (i.e., SimK, CIM, SF, and TKM)
and two oculovisual parameters (i.e., BCVA and CSF).
Histologically, pterygium is composed of the head of
the conjunctival epithelium and hyperproliferative
vascularization along the body of the degenerated
connective
tissue,
which
signifies
elastolic
degeneration.1–3 Because of these characteristics,
pterygium was previously considered a degenerative
disorder. However, recent studies have proven that
Makara J Health Res.
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pterygium also has proliferative histological
characteristics,4–9 such as mild dysplasia, local
invasiveness, and abnormal p53 gene expression, and
clinical features, including a high recurrence rate
following pterygium excision.
Pterygium is usually associated with adult cataract,
which often co-occurs with the growth. Thus,
determination of the appropriate time for cataract
removal may be difficult because the intraocular (IOL)
power calculation for cataract could be inaccurate.
Inaccuracies in IOL power calculation could occur due
to the anterior corneal curvature was not fully
recovered, which could give rise to errors in corneal
measurement. Our literature search revealed limited
evidence on the minimum duration needed for corneas
to recover after pterygium excision using the fibrin
glue adhesive method.
Koranyi, Seregard, and Kopp first introduced the fibrin
glue adhesive method based on their “cut-and-paste”
approach for treating pterygium. 31 This method
features a conjunctival autograft attached with a fibrin
glue adhesive rather than sutures. Fibrin glue is a
blood-derived product consisting of fibrinogen and
thrombin. Thrombin activates fibrinogen, and an
adhesive fibrin network is formed.32 This method
adopts a similar normal biological reaction in a wound
healing process and has been proven to result in a
lowest risk of pterygium recurrence (0 – 8.16%)
compared with other methods. 27,28 Indeed, no
recurrence of pterygium was noted throughout the
duration of the present study. The fibrin glue adhesive
method shows promising results and several
advantages. For example, this method is sutureless,
which means fewer post-operative complications, less
operating time, and high safety and efficiency.18,33,34
Significant reductions in SimK, CIM, SF, and TKM
were noted within the first 3 months post-surgery (all p
< 0.001) in this work; stabilization of these indices
occurred from the third month onward. Variations in
SimK, CIM, SF, and TKM signify that the anterior
corneal curvature returns to its standard prolate shape
and that corneal compression due to localized
flattening by pterygium progression is reduced. 21
Changes in SimK and CIM represent changes to the
anterior apical corneal curvature, which could be
associated with the acuity of central vision as
pterygium covers the central 5-mm of the central
cornea. Low SimKs indirectly signify minimal residual
corneal astigmatism, while a higher value of, for
instance, over 0.68 μm signifies an irregular corneal
curvature.35 Decreasing the CIM to the normal range
of 0.03–0.68 μm is crucial to ensure that the central
corneal curvature returns to its original state. 35 Recent
work revealed a significant increment in CIM as
pterygium progresses. 36
August 2020 | Vol. 24 | No. 2
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Changes in SF and TKM reflect changes in the anterior
apical corneal curvature, which could be associated
with overall visual quality. Increments in SF and TKM
indicate increases in overall corneal irregularity and
corneal instability due to pterygium progression. An SF
of greater than 0.47, which indicates corneal flattening at
the periphery, is considered abnormal. A previous
work reported similar findings.41 A TKM of greater than
47.3 dioptres (D) indicates an increase in average
keratometry, which reflects a significant variation of the
corneal curvature.37 TKM utilized elevation data
obtained by corneal topographer and compare the toric
reference to the actual cornea. This provides better toric
representation of a patient's cornea and also its corneal
regularity. An earlier work found that elevation data
analyzed based on TKM values showed better accuracy
in measurement of astigmatism in irregular cornea. 38
Recent research also revealed that pterygium induces
higher corneal toricity as reflected by abnormal TKM
values which indicates higher elevation data obtained in
pterygium cases due to increase in corneal toricity of the
anterior corneal curvature.37,42
BCVA and CSF represent the oculovisual function
status, which indirectly provides information on visual
quality. Changes to the corneal surface cause by the
pterygium may affect visual quality. The results of this
study showed significant improvements in BCVA and
CSF within the first 3 months post-surgery (all p <
0.001) and stable values from the third month onward.
This finding agrees with previous reports.8,21 Some
researchers have suggested that the anterior corneal
curvature stabilizes and recovers to its original state 3
months post-surgery. However, any obstruction during
corneal healing process could cause corneal
irregularity and reductions in visual function.44
The findings suggest that corneal stabilization occurs
because of two reasons: pterygium morphology and
mechanical-traction on the anterior corneal surface due to
pterygium progression. First, the pterygium morphology
could affect the corneal stabilization as pterygium
fibrovascular tissue could present as a thick pterygium
tissue and this could change the curvature of the anterior
corneal surface.41 Previous works had commented that an
increase in thickness could suggest excessive
proliferative disorders.39,40 The excessive proliferative
growth of the pterygium could induce corneal
compression, which may also lead to increases in the
corneal indices and result in induced astigmatism.
Considering the mechanical traction on the anterior
corneal surface due to pterygium progression, this
study suggests that pterygium indirectly induces
localized flattening, which could lead to corneal
compression, as the growth progresses. 41 Compression
of the anterior corneal curvature could be due to two
reasons. First, the tension of the fibrovascular
Makara J Health Res.

pterygium tissue on the cornea, which stretches from
the bulbar conjunctiva, may increase, thereby causing
corneal flattening. Second, corneal compression may
occur because of the fibrovascular tissue pressing
against the corneal surface. 42,43 However, our literature
search revealed little information on this topic.
This study presents some limitations that must be
taken into account when interpreting the results. First,
this study includes primary pterygia with a wide range
of corneo-pterygium total areas and multiple
pterygium types, which could indirectly cause a high
SD during measurement. An extremely large
pterygium could also cause errors in topographic
measurement because the instrument may be unable to
detect the central cornea as its reference.
The current study suggests that a broader view is
needed to evaluate how pterygium induces changes to
the anterior corneal curvature. Previous theories
mainly focusing on pterygium size, width, and length
are inadequate to explain the changes that may occur
over the course of pterygium progression. 11,41,44 The
results of this study indicate that the combination of a
corneo-pterygium approach and a good understanding
of pterygium grades based on the translucence of the
growth could help predict the changes induced by
pterygium on the corneal surface.

Conclusion
The controlled partial avulsion fibrin glue technique
provides stable corneal and visual recovery within 3
months post-surgery with zero recurrence of pterygium.
It may improve surgical outcomes with long-term
recurrence rates equal to or lower than those previously
reported. Corneal surface recovery is completed after
the third month of the excision procedure.
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